Literature DB >> 26491049

Agonist binding to β-adrenergic receptors on human airway epithelial cells inhibits migration and wound repair.

Elizabeth R Peitzman1, Nathan A Zaidman2, Peter J Maniak1, Scott M O'Grady3.   

Abstract

Human airway epithelial cells express β-adrenergic receptors (β-ARs), which regulate mucociliary clearance by stimulating transepithelial anion transport and ciliary beat frequency. Previous studies using airway epithelial cells showed that stimulation with isoproterenol increased cell migration and wound repair by a cAMP-dependent mechanism. In the present study, impedance-sensing arrays were used to measure cell migration and epithelial restitution following wounding of confluent normal human bronchial epithelial (NHBE) and Calu-3 cells by electroporation. Stimulation with epinephrine or the β2-AR-selective agonist salbutamol significantly delayed wound closure and reduced the mean surface area of lamellipodia protruding into the wound. Treatment with the β-AR bias agonist carvedilol or isoetharine also produced a delay in epithelial restitution similar in magnitude to epinephrine and salbutamol. Measurements of extracellular signal-regulated kinase phosphorylation following salbutamol or carvedilol stimulation showed no significant change in the level of phosphorylation compared with untreated control cells. However, inhibition of protein phosphatase 2A activity completely blocked the delay in wound closure produced by β-AR agonists. In Calu-3 cells, where CFTR expression was inhibited by RNAi, salbutamol did not inhibit wound repair, suggesting that β-AR agonist stimulation and loss of CFTR function share a common pathway leading to inhibition of epithelial repair. Confocal images of the basal membrane of Calu-3 cells labeled with anti-β1-integrin (clone HUTS-4) antibody showed that treatment with epinephrine or carvedilol reduced the level of activated integrin in the membrane. These findings suggest that treatment with β-AR agonists delays airway epithelial repair by a G protein- and cAMP-independent mechanism involving protein phosphatase 2A and a reduction in β1-integrin activation in the basal membrane.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  biased agonism; carvedilol; epinephrine; impedance sensing; β-arrestin signaling

Mesh:

Substances:

Year:  2015        PMID: 26491049      PMCID: PMC4683215          DOI: 10.1152/ajpcell.00159.2015

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  51 in total

Review 1.  Epithelial repair mechanisms in the lung.

Authors:  Lynn M Crosby; Christopher M Waters
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-04-02       Impact factor: 5.464

Review 2.  The role of epithelial injury and repair in the origins of asthma.

Authors:  Tillie-Louise Hackett; Darryl A Knight
Journal:  Curr Opin Allergy Clin Immunol       Date:  2007-02

Review 3.  Epithelium dysfunction in asthma.

Authors:  Stephen T Holgate
Journal:  J Allergy Clin Immunol       Date:  2007-12       Impact factor: 10.793

Review 4.  The role of the airway epithelium and its interaction with environmental factors in asthma pathogenesis.

Authors:  Stephen T Holgate; Graham Roberts; Hasan S Arshad; Peter H Howarth; Donna E Davies
Journal:  Proc Am Thorac Soc       Date:  2009-12

Review 5.  Airway epithelial cells: current concepts and challenges.

Authors:  Ronald G Crystal; Scott H Randell; John F Engelhardt; Judith Voynow; Mary E Sunday
Journal:  Proc Am Thorac Soc       Date:  2008-09-15

Review 6.  β2-agonist therapy in lung disease.

Authors:  Mario Cazzola; Clive P Page; Paola Rogliani; M Gabriella Matera
Journal:  Am J Respir Crit Care Med       Date:  2013-04-01       Impact factor: 21.405

Review 7.  Cell death, remodeling, and repair in chronic obstructive pulmonary disease?

Authors:  Peter M Henson; R William Vandivier; Ivor S Douglas
Journal:  Proc Am Thorac Soc       Date:  2006-11

Review 8.  Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.

Authors:  Sally Spencer; David J Evans; Charlotta Karner; Christopher J Cates
Journal:  Cochrane Database Syst Rev       Date:  2011-10-05

Review 9.  Repair after acute lung injury: molecular mechanisms and therapeutic opportunities.

Authors:  Adrián González-López; Guillermo M Albaiceta
Journal:  Crit Care       Date:  2012-12-12       Impact factor: 9.097

Review 10.  Impact of extrafine formulations of inhaled corticosteroids/long-acting beta-2 agonist combinations on patient-related outcomes in asthma and COPD.

Authors:  Nicola Scichilone; Alida Benfante; Luca Morandi; Federico Bellini; Alberto Papi
Journal:  Patient Relat Outcome Meas       Date:  2014-11-27
View more
  4 in total

Review 1.  Exploiting the potential of lung stem cells to develop pro-regenerative therapies.

Authors:  Robert E Hynds
Journal:  Biol Open       Date:  2022-10-14       Impact factor: 2.643

Review 2.  Neuronal regulation of immunity: why, how and where?

Authors:  Maya Schiller; Tamar L Ben-Shaanan; Asya Rolls
Journal:  Nat Rev Immunol       Date:  2020-08-18       Impact factor: 53.106

Review 3.  Nano and Microsensors for Mammalian Cell Studies.

Authors:  Ioana Voiculescu; Masaya Toda; Naoki Inomata; Takahito Ono; Fang Li
Journal:  Micromachines (Basel)       Date:  2018-08-31       Impact factor: 2.891

4.  Carvedilol induces biased β1 adrenergic receptor-nitric oxide synthase 3-cyclic guanylyl monophosphate signalling to promote cardiac contractility.

Authors:  Qingtong Wang; Ying Wang; Toni M West; Yongming Liu; Gopireddy R Reddy; Federica Barbagallo; Bing Xu; Qian Shi; Bingqing Deng; Wei Wei; Yang K Xiang
Journal:  Cardiovasc Res       Date:  2021-08-29       Impact factor: 10.787

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.